chevron-down Created with Sketch Beta.
July 15, 2022

San Francisco reaches $54M settlement in opioid litigation with Allergan and Teva

On July 12, San Francisco City Attorney David Chiu announced a $54 million settlement agreement with two defendants in the city’s landmark trial against opioid manufacturers. On the eve of closing arguments, Allergan and Teva agreed to pay San Francisco $34 million in cash and provide the city with $20 million worth of Narcan, an overdose reversal drug. Allergan and Teva have now been severed from the trial, and closing arguments proceeded against Walgreens, the remaining defendant. 

The material in all ABA publications is copyrighted and may be reprinted by permission only. Request reprint permission here.